Sernova Corp
TSX:SVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Sernova Corp (SVA) under the Base Case is 0.19 CAD per share. Compared with the current market price of 0.105 CAD, the stock appears Undervalued by 45% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Sernova Does
Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is engaged in the development of its Cell Pouch and associated technologies, including therapeutic cells for the treatment of chronic diseases and local immune protection technologies. The company is focused on developing a treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted and prevascularized medical device, protected from immune system attack.
- Headquarters
- Canada CA
- IPO date
- Apr 15, 1999
Continue SVA Research
Decided on Sernova? Get an email when SVA reaches the price you’d buy at. Free with an account.
Other Sernova listings
What is the Intrinsic Value of one SVA stock?
The intrinsic value for Sernova Corp (SVA) under the Base Case is 0.19 CAD.
Is SVA stock undervalued or overvalued?
Compared with the current market price of 0.105 CAD, the stock appears Undervalued by 45% .